The AI in genomics market is set for rapid growth, driven by increasing adoption of artificial intelligence technologies in healthcare and life sciences. AI’s ability to process and analyze vast genomic datasets with greater speed and accuracy is revolutionizing personalized medicine, enabling more precise diagnostics and targeted therapies. The technology’s role in drug discovery and genetic research is also gaining traction, as it accelerates the identification of genetic mutations and their associated risks.
By 2033, the AI in genomics market is projected to reach $9.5 billion, growing at a CAGR of 21.8%. This expansion reflects the increasing demand for AI-powered genomic solutions across sectors such as biotechnology, pharmaceuticals, and academic research, where AI is becoming a cornerstone in genetic analysis and innovation.
Download Research Report Sample & TOC:
https://www.globalinsightservices.com/request-sample/?id=GIS20765
(We are providing report as per your research requirement, including the Latest Industry Insight’s Evolution and Potential)
- 18 – Chapter
- 302 – Pages
- Industry: Pharmaceuticals
Key trends:
The Artificial Intelligence (AI) in genomics market is experiencing rapid expansion, driven by transformative trends and key technological advancements. A primary trend is the integration of AI with genomic sequencing technologies, significantly improving the speed and accuracy of genetic data analysis. This synergy is enabling breakthroughs in personalized medicine, allowing healthcare providers to deliver more precise diagnostics and develop targeted therapies based on individual genetic profiles.
Another major trend is the increasing use of AI-powered tools in drug discovery and development. These tools are expediting the identification of viable drug candidates and streamlining the drug development process, leading to substantial cost and time savings compared to traditional methods. The rise of cloud-based AI platforms is further enhancing global collaboration in genomics research, facilitating data sharing and large-scale analysis among scientists.
Get Special Pricing of Reports with your Requirements:
https://www.globalinsightservices.com/request-special-pricing/GIS20765
Market Segmentation:
| Type | Machine Learning, Deep Learning, Supervised Learning, Unsupervised Learning, Reinforcement Learning, Natural Language Processing, Computer Vision |
| Product | Software, Platforms, Tools, Kits |
| Services | Consulting, Integration, Maintenance, Training |
| Technology | Genomic Sequencing, Gene Editing, CRISPR, Synthetic Biology |
| Component | Hardware, Software, Services |
| Application | Drug Discovery, Precision Medicine, Diagnostics, Therapeutics, Biomarker Discovery |
| End User | Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Healthcare Providers, Academic Institutions |
| Deployment | Cloud-based, On-premise, Hybrid |
| Solutions | Data Management, Data Analysis, Workflow Automation |
Inquiry before Buying:
https://www.globalinsightservices.com/inquiry-before-buying/GIS20765
Data Summary:
| HISTORICAL PERIOD | 2017-2022 |
| FORECAST PERIOD | 2024-2033 |
| BASE YEAR | 2023 |
| MARKET SIZE IN 2023 | 1.3 Billion |
| MARKET SIZE IN 2033 | 9.5 Billion |
| CAGR | 21.8% |
| SEGMENTS COVERED | Type, Product, Services, Technology, Component, Application, End User, Deployment, Solutions |
| ANALYSIS COVERAGE | Market Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events, SWOT Analysis and Developments |
Research Scope:
- Estimates and forecasts the overall market size across type, application, and region.
- Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
- Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
- Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
- Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
- Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
- Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.
Procure Complete Report (302 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.globalinsightservices.com/checkout/single_user/GIS20765
Key Players:
- Deep Genomics
- BenevolentAI
- Insilico Medicine
- SOPHiA GENETICS
- Genoox
- Fabric Genomics
- FDNA
- Eagle Genomics
- GNS Healthcare
- Genomenon
- Envisagenics
By Region
- North America (U.S., Canada, Mexico)
- Europe (UK, Germany, France, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, India, South Korea, Rest of Asia-Pacific)
- Latin America (Brazil, Argentina, Rest of Latin America)
- Middle East and Africa (UAE, Saudi Arabia, Rest of Middle East And Africa)
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Infographic excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Us:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.